Search Result "mGlu<sub>2/3</sub> receptor agonists"
When is a Proof-of-Concept (POC) not a POC? Pomaglumetad (LY2140023) as a Case Study for Antipsychotic Efficacy
Journal: Current Pharmaceutical Design
Volume: 21 Issue: 26 Year: 2015 Page: 3788-3796
Author(s): Gerard J. Marek
Scope and Limitation of Ligand Docking: Methods, Scoring Functions and Protein Targets
Journal: Current Computer-Aided Drug Design
Volume: 1 Issue: 3 Year: 2005 Page: 275-306
Author(s): L. David, P. Aadal Nielsen, M. Hedstrom, B. Norden
Apply Filters
Volume Years
Content Type
Ads